MedPath

Personality Traits and Its Impact on Quality of Life and Clinical Outcome Evaluation in Crohn's Patients

Not Applicable
Conditions
Crohn's Disease
Interventions
Other: Personality Traits Questionnaires
Registration Number
NCT01887548
Lead Sponsor
Jinling Hospital, China
Brief Summary

Quality of life is recommended as one of essential parameters to evaluate treatment effect and clinical outcome in patients with Crohn's disease (CD). Recent studies reported that several disease-unrelated variables may affect quality of life in CD patients. This study is dedicated to investigate the influence of various personality traits on quality of life, and whether or not they should be taken into account when evaluating clinical outcomes in patients with CD.

Detailed Description

This is a prospective, single-center study.

All enrolled patients are divided into 2 groups:

* Group 1: quiescent CD group (CDAI≤150 points)

* Group 2: active CD group (CDAI\>150 points)

All enrolled patients are required to accomplish the following questionnaires at visit:

* Inflammatory Bowel Disease Questionnaire (IBDQ)

* Neuroticism (N) and Lie (L) subscale of the Eysenck Personality Inventory (EPI)

* Hospital Anxiety and Depression Scale (HADS)

* Buss-Perry Aggression (BPA) questionnaire

All questionnaires are translated and validated in Chinese population.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
80
Inclusion Criteria
  • 18-65 years old
  • a definite diagnosis of CD
Exclusion Criteria
  • current or previous mental disorders
  • receiving or once received psychotherapy
  • presence of major medical conditions (such as necessity of an operation)
  • chronic disease history other than inflammatory bowel disease
  • unwilling to participate in or cannot accomplish current study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Active CDPersonality Traits QuestionnairesPatients whose CDAI score \>150 points would be enrolled in this group.
Quiescent CDPersonality Traits QuestionnairesPatients whose CDAI score ≤150 points would be enrolled in this group.
Primary Outcome Measures
NameTimeMethod
IBDQone week

Inflammatory Bowel Disease Questionnaires (IBDQ) is the most widely used and validated disease-specific instrument, which contains 32 items and assesses four aspects (subscales) of quality of life: emotional function (12 items), social function (5 items), bowel function (10 items) and systemic symptom (5 items).

Secondary Outcome Measures
NameTimeMethod
Eysenck Personality Inventory (EPI)one week

To assess neuroticism and social conformity and desirability, the Neuroticism and Lie subscales from the Eysenck Personality Inventory (EPI) were adopt in current study. Twenty-three items are designed to evaluate neuroticism (Neuroticism subscale) and the other 21 items are assigned for social desirability (Lie subscale).

Hospital Anxiety and Depression Scale (HADS)one week

The Hospital Anxiety and Depression Scale (HADS) was first developed in 1983 and has been extensively used in subsequent studies to identify the potential anxiety and depression in nonpsychiatric hospitalized patients. This questionnaire includes separated Anxiety and Depression subscales with seven items, respectively.

Buss Perry Aggregation (BPA) questionnaireone week

BPA is one of the most popular self-report inventories for the measurement of four different dimensions (anger, hostility, physical aggression and verbal aggression). This 29-item questionnaire is scored with a 5-level scale for each question, contributing to a total score and four subscales of each dimension. A higher score suggests a higher level of aggression feelings.

Trial Locations

Locations (1)

Department of Surgery, Jinling Hospital

🇨🇳

Nanjing, Jiangsu, China

© Copyright 2025. All Rights Reserved by MedPath